Clinical Trials on Hypertension Complicated With Type 2 Diabetes in Korea, Democratic People's Republic of
Total 565 results
-
National Nutrition and Food Technology InstituteUnknownNon Insulin Dependent DiabetesIran, Islamic Republic of
-
National Nutrition and Food Technology InstituteCompletedNon Insulin Dependent DiabetesIran, Islamic Republic of
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Tehran University of Medical SciencesCompletedDiabetes Mellitus Type IIIran, Islamic Republic of
-
Tehran University of Medical SciencesResearch Center for Rational Use of DrugsCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
NovartisCompletedType 2 Diabetes MellitusTaiwan, Philippines, Italy, Germany, Romania, Hungary, Australia, Korea, Republic of, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Celltrion Pharm, Inc.Active, not recruiting
-
Isfahan University of Medical SciencesCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Isfahan University of Medical SciencesCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Korea, Republic of, China, Turkey
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, India
-
Baqiyatallah Medical Sciences UniversityCompletedDetermining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMacedonia, The Former Yugoslav Republic of
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
Bristol-Myers SquibbCompletedDiabetes Type 2United States, Canada, Korea, Republic of, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of
-
Isfahan University of Medical SciencesShahid Motahari Hospital of Fooladshahr, Isfahan Steel Company, IsfahanCompletedType 2 Diabetic PatientsIran, Islamic Republic of
-
AstraZenecaCompleted
-
Kerman Medical UniversityAfzalipour HospitalNot yet recruitingDiabetes Mellitus, Type 2 | Insulin ResistanceIran, Islamic Republic of
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
Baqiyatallah Medical Sciences UniversityUnknownDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
AstraZenecaCompletedDiabetes Mellitus Type 2United States, Australia, Canada, Denmark, Finland, Germany, Israel, Italy, Japan, Korea, Republic of, Norway, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Taiwan, Korea, Republic of
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Korea, Republic of, Russian Federation
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of, Finland, Spain, Denmark, Germany, Israel, Japan, Norway, Sweden, Taiwan, United Kingdom
-
SanofiCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Malaysia, Taiwan
-
Novo Nordisk A/SEnrolling by invitation
-
University of Banja LukaEnrolling by invitationDiabetes Mellitus, Type 2Bosnia and Herzegovina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Israel, Korea, Republic of, Turkey, Italy, Belgium, United Kingdom, Greece, Ireland, Sweden, Denmark, Finland, France, Czech Republic
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, Philippines, China, India
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Korea, Republic of, Taiwan
-
Seoul National University HospitalGangnam Severance HospitalRecruitingDiabetes Mellitus, Type 2 | Endocrine System Diseases | Dyslipidemias | Nutritional and Metabolic DiseasesKorea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, China, India
-
TakedaTerminatedType 2 Diabetes MellitusTaiwan, China, Korea, Republic of, New Zealand, Australia
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedOverweight | Type 2 Diabetes | ObeseIran, Islamic Republic of
-
Yuhan CorporationCompletedDiabetes Mellitus, Type 2 | Neuropathic PainKorea, Republic of
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Isfahan University of Medical SciencesCompletedType II Diabetic Patients With NephropathyIran, Islamic Republic of
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Hoffmann-La RocheTerminatedDiabetes Mellitus Type 2China, Hong Kong, Korea, Republic of, Philippines, Taiwan, Malaysia, Thailand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Japan, Taiwan, India
-
AstraZenecaCompletedLow Density Lipoprotein Cholesterol Goal AchievementKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
Eli Lilly and CompanyCompletedType 2 DiabetesChina, Australia, Korea, Republic of, India